Bausch Health Cos Net Worth 2010-2024 | BHC

Interactive chart of historical net worth (market cap) for Bausch Health Cos (BHC) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bausch Health Cos net worth as of December 26, 2024 is $2.75B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.752B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $25.626B 8.41
Dr Reddy's Laboratories (RDY) India $12.997B 24.87
BridgeBio Pharma (BBIO) United States $5.365B 0.00
Supernus Pharmaceuticals (SUPN) United States $2.003B 27.28
Amphastar Pharmaceuticals (AMPH) United States $1.835B 11.03
Personalis (PSNL) United States $0.442B 0.00
Taysha Gene Therapies (TSHA) United States $0.381B 26.57
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.034B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00